Cardiology now has more than 100 FDA cleared AI algorithms; experts say that is just the beginning

Example of a totally AI driven echocardiography workflow on the new Siemens Origin ultrasound system unveiled in 2023. The AI did all the work on this screen, taking a 3D echo exam and automatically segmenting the anatomy, contoured all the chambers, found the ideal views to display and then calculated all the measurements in seconds. Photo by Dave Fornell at TCT 2023. 

Example of a totally AI driven echocardiography workflow on the new Siemens Origin ultrasound system unveiled in 2023. The AI did all the work on this screen, taking a 3D echo exam and automatically segmenting the anatomy, contoured all the chambers, found the ideal views to display and then calculated all the measurements in seconds. Photo by Dave Fornell at TCT 2023. 

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

FDA has now cleared 700 AI healthcare algorithms, more than 76% in radiology

AI applications developed by Annalise.ai and commercialized outside the U.S. The company is working on gaining FDA for these and had several FDA clearances granted this past year. Photo by Dave Fornell. #RSNA #RSNA23 #RSNA2023

A sheet at RSNA 2023 showing AI applications developed by the radiology AI vendor Annalise.ai and commercialized outside the U.S. The company is working on gaining FDA for these and had several FDA clearances granted this past year.

Medical imaging makes up 76% of all the FDA-cleared artificial intelligence clinical algorithms used for direct patient care.

Design by Adaptive Theme